Loading...
Loading...
AEMD| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 54.4K |
| Gross Profit | -54.4K |
| Operating Expense | 3,807.4K |
| Operating I/L | -3,665.3K |
| Other Income/Expense | -142.1K |
| Interest Income | 0.0K |
| Pretax | -3,807.4K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -3,807.4K |
Aethlon Medical, Inc. is a medical technology company specializing in developing products to diagnose and treat life-threatening diseases. Their flagship product, the Aethlon Hemopurifier, is a clinical-stage immunotherapeutic device designed to remove tumor-derived exosomes and life-threatening viruses from the human circulatory system, including COVID-19 virus and associated variants. The company generates revenue through the sale of the Aethlon Hemopurifier and related services, catering to patients with critical illnesses. Additionally, Aethlon Medical, Inc. collaborates with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer.
